Investment Summary

The BroadOak Fund Invests In Accellix

On December 13, 2021, growth capital firm The BroadOak Fund invested in life science company Accellix

Investment Highlights
  • This is The BroadOak Fund’s 13th transaction in the Life Science sector.
  • This is The BroadOak Fund’s 15th transaction in the United States.
  • This is The BroadOak Fund’s 7th transaction in California.

Investment Summary
Date 2021-12-13
Target Accellix
Sector Life Science
Investor(s) The BroadOak Fund
Deal Type Growth Capital

Target

Accellix

San Jose, California, United States
Accellix is a biotechnology company dedicated to developing and commercializing the Accellix Platform to enable its customers in the field of cell and gene therapy to meet their critical QC requirements as they advance life changing therapies benefiting patients worldwide. Accellix was founded in 2007 and is based in San Jose, California.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

The BroadOak Fund

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Size Small
Type Sector Focused
DESCRIPTION

The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.

DEAL STATS #
Overall 16 of 25
Sector (Life Science) 13 of 20
Type (Growth Capital) 6 of 14
State (California) 7 of 9
Country (United States) 15 of 23
Year (2021) 5 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-09 Biocare Medical

Pacheco, California, United States

Biocare Medical is a provider of immunohistochemistry (IHC) instrumentation, as well as a full range of reagents for IHC and molecular testing. The company engages in IHC and molecular diagnostic reagents, including simultaneous Multiplex IHC tests that provide increased confidence at critical diagnostic decision points, positively influencing patient therapy while accelerating turnaround time. Biocare Medical was founded in 1997 and is based in Pacheco, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-18 PhenoVista Biosciences

San Diego, California, United States

PhenoVista Biosciences is a CRO specializing in modern human cell-based in vitro assay development and analysis. PhenoVista Biosciences was founded in 2014 and is based in San Diego, California.

Buy -
Mergr

Product

Company

Legal